4//SEC Filing
Miller Steve 4
Accession 0001161697-24-000523
CIK 0001369568other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:24 PM ET
Size
7.2 KB
Accession
0001161697-24-000523
Insider Transaction Report
Form 4
Miller Steve
VP Development & Management
Transactions
- Exercise/Conversion
Options to purchase common stock
2024-12-13−235,000→ 1,552,176 totalExercise: $4.01Exp: 2025-01-02→ Common Stock (235,000 underlying) - Exercise/Conversion
Common stock, par value $0.001 per share
2024-12-13$4.01/sh+235,000$942,350→ 921,996 total
Footnotes (1)
- [F1]Options vested in three annual tranches beginning on January 2, 2019.
Documents
Issuer
CATALYST PHARMACEUTICALS, INC.
CIK 0001369568
Entity typeother
Related Parties
1- filerCIK 0001402535
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:24 PM ET
- Size
- 7.2 KB